Nureca: GST demand for FY22 dropped after rectification, Rs 15.4 lakh ITC reversed

Regulatory & Legal View source PDF Explain this filing

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.9%Reaction day

₹320.75

prior close

₹310.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-5.2% vs market

Medical Equipment & Supplies peers, median of 12sector+1.2%-6.1% vs sector

On the reaction day the stock moved 5.2 pts less than Nifty Microcap 250 and 6.1 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+1.6

30m

+1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.9+0.3-5.2+1.2-6.1

Next day

-6.5+0.5-7.0-0.8-5.7

-8.0+0.1-8.1-0.3-7.7

-4.7+0.7-5.3+1.6-6.2

-0.3+0.4-0.7-0.7+0.4

+2.9+0.7+2.2+1.0+1.9

+5.5+0.1+5.5+0.7+4.9

15d

+3.8+1.5+2.4+1.0+2.8

+5.8+0.3+5.5+0.4+5.4

+2.5-6.2+8.7-10.6+13.1

—————

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nureca received a Final Rectification Order from the GST Department on Aug 6, 2026, for tax period 2021-22. The original DRC-07 order under Section 73(9) of the CGST Act was rectified under Section 161, and the related GST demand was dropped by the authorities. The matter was settled by reversing Input Tax Credit of about Rs 15.4 lakh. This filing provides additional details to an earlier announcement dated Aug 7, 2026.

Likely market impact

Minor financial hit of about Rs 15.4 lakh from ITC reversal. The main GST demand was dropped, so no major burden.